IP Library › Granted Patent US 9,693,721
Granted Patent B2
US 9,693,721 · App. 14/742,137 · Granted Jul 4, 2017

Polymer membranes for continuous analyte sensors

Inventors: Robert J. Boock (Carlsbad, CA); Monica A. Rixman (Medford, MA); Huashi Zhang (San Diego, CA); Michael J. Estes (Poway, CA); Kristina Lawrence (Escondido, CA)
Assignee: DexCom, Inc.
A61B5/14865A61B5/1468A61B5/1473A61B5/1486A61B5/14532A61B5/14546C12Q1/006G01N27/40A61B5/7203
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,721
App. No.
14/742,137
Granted
Jul 4, 2017
Kind
B2
Abstract

Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.

Claims (23)

1. A device for in vivo measurement of a glucose concentration, the device comprising:

a transcutaneous sensor configured to measure a signal indicative of a glucose concentration in a host, wherein the sensor comprises an electroactive surface; and

a membrane located over the sensor, wherein the membrane comprises:

a second domain comprising a polymer comprising a plurality of repeating hard segments and repeating soft segments, wherein a soft segment of the plurality of repeating soft segments has a molecular weight from about 200 Daltons to about 50,000 Daltons, wherein a hard segment of the plurality of repeating hard segments has a molecular weight from about 160 Daltons to about 10,000 Daltons, wherein the polymer comprises a hydrophilic segment, wherein the second domain comprises both hydrophilic and hydrophobic regions, whereby diffusion of glucose and oxygen through the second domain is controlled; and

sensor electronics operably connected to the sensor, wherein the sensor electronics are configured to measure a current flow produced by the sensor to generate sensor data indicative of glucose concentration.

2. The device of claim 1 , wherein the polymer is a polyurethaneurea.

3. The device of claim 1 , wherein the hydrophilic segment comprises acrylate.

4. The device of claim 1 , wherein the membrane comprises a third domain configured to reduce permeation therethrough of an interfering species.

5. The device of claim 4 , further comprising a first domain comprising an enzyme configured to react with glucose to produce a measured species, wherein the third domain is located between the sensor and the first domain.

6. The device of claim 4 , wherein the third domain comprises a polymer comprising ionic components.

7. The device of claim 4 , wherein the third domain is configured to limit diffusion of interfering species with a molecular weight greater than a molecular weight of hydrogen peroxide.

8. The device of claim 1 , wherein the polymer is polyurethaneurea, wherein the hydrophilic segment comprises acrylate.

9. The device of claim 1 , wherein the polymer is polyurethaneurea, wherein the hydrophilic segment comprises acrylate, wherein the membrane comprises a third domain configured to reduce permeation therethrough of an interfering species.

10. The device of claim 1 , further comprising a first domain comprising an enzyme configured to react with glucose to produce a measured species, wherein the polymer is polyurethaneurea, wherein the hydrophilic segment comprises acrylate, wherein the membrane comprises a third domain configured to reduce permeation therethrough of an interfering species, wherein the third domain is located between the sensor and the first domain.

11. The device of claim 1 , wherein the hydrophilic segment is selected from the group consisting of: polyvinyl acetate, poly(ethylene glycol), polyacrylamide, acetates, polyethylene oxide, polyvinylpyrrolidone, and poly ethyl acrylate.

12. The device of claim 1 , wherein the polyurethane polymer comprises silicone.

13. The device of claim 12 , wherein the polymer comprises from about 10% to about 50% silicone by weight.

14. The device of claim 13 , wherein the polymer comprises from about 20% to about 40% silicone by weight.

15. The device of claim 1 , wherein the polymer is polyurethaneurea, wherein the hydrophilic segment comprises acrylate, wherein the polyurethane polymer comprises silicone.

16. The device of claim 1 , wherein the polymer comprising the hydrophilic segment comprises from about 5% to about 50% by weight of the blend.

17. The device of claim 1 , wherein the polyurethane polymer is polyurethaneurea, wherein the hydrophilic segment comprises acrylate, wherein the polymer comprising the hydrophilic segment comprises from about 5% to about 50% by weight of the blend.

18. The device of claim 1 , wherein the device is configured to have a sensor session from 5 to 10 days.

19. The device of claim 1 , wherein the sensor is configured to continuously measure a signal indicative of a glucose concentration in a host.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: BOOCK, ROBERT; RIXMAN, MONICA A.; ZHANG, HUASHI; ESTES, MICHAEL J.; LAWRENCE, KRISTINA
To: DEXCOM, INC.
Reel/Frame 035955/0048 →
Continuity (6)
Continuation 14517663 · Oct 17, 2014
Continuation 14058154 · Oct 18, 2013
Continuation 12718299 · Mar 5, 2010
Continuation In Part 12413231 · Mar 27, 2009
Provisional Application 61040594 · Mar 28, 2008
Related Publication 20150282750A1 · Oct 8, 2015